
OpGen OPGN
Quartalsbericht 2025-Q3
hinzugefügt 19.11.2025
OpGen EV 2011-2026 | OPGN
EV Jährlich OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3 M | 14.3 M | 11.2 M | -4.02 M | 49.5 M | 5.88 M | 10.1 M | 11.2 M | 22.5 M | 9.79 M | 9.97 M | 4.99 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 49.5 M | -4.02 M | 13 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.39 | -1.31 % | $ 35.1 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.16 | -1.69 % | $ 6.32 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 16.69 | -6.86 % | $ 889 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.25 | 0.06 % | $ 175 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 23.43 | -6.99 % | $ 651 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 175.55 | 0.27 % | $ 8.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 192.99 | -1.63 % | $ 138 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.3 | 16.02 % | $ 10.2 M | ||
|
Illumina
ILMN
|
15.3 B | $ 123.67 | -3.38 % | $ 19.7 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.02 | -5.12 % | $ 454 M | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 28.13 | 0.29 % | $ 20 B | ||
|
Guardant Health
GH
|
15.2 B | $ 87.17 | -6.11 % | $ 10.9 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.74 | 0.37 % | $ 88.9 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.2 | 2.33 % | $ 5.05 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 106.7 | 0.15 % | $ 8.8 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 273.26 | -0.53 % | $ 22.7 B | ||
|
Celcuity
CELC
|
5.57 B | $ 124.64 | 6.58 % | $ 5.83 B | ||
|
Medpace Holdings
MEDP
|
14 B | $ 501.5 | -3.68 % | $ 14.5 B | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 81.43 | 1.75 % | $ 5.5 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.44 | -6.92 % | $ 411 M | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 197.82 | -0.5 % | $ 22 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.94 | -3.38 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 10.04 | -2.95 % | $ 2.18 B | ||
|
ENDRA Life Sciences
NDRA
|
4.49 M | $ 5.31 | 2.71 % | $ 4.18 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.05 | -1.22 % | $ 382 M | ||
|
Natera
NTRA
|
5.53 B | $ 203.0 | -3.71 % | $ 20 B | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M |